I P R info Liability and Compensation for Biosafety

Prepared by Eyvette Flynn, Institute for Agriculture and Trade Policy

No. 21, January 30, 1998

Information About Intellectual Property Rights, Biotechnology and Biodiversity

Unintended negative consequences of genetically engineered organisms are already being felt around the world. Adequate provisions for liability and compensation are needed in the Biosafety Protocol to create incentives for responsible corporate behavior, and to create disincentives for premature releases of GMOs that have been inadequately tested for the effects on biodiversity and human health.

Beneficial insects are being killed.

Transgenic seeds are performing poorly; farmers' economic status is threatened.

Early field trials and on-farm plantings of transgenic cotton and oil seed have shown more production-related problems compared to conventional seed including low seed vigor, reduced yields and poor plant health, in addition to high economic costs.

Unapproved releases are occurring.

Human health concerns grow.